WAYNE, Pa. - Teleflex Incorporated (NYSE: NYSE:TFX), a global provider of medical technologies, has declared a quarterly cash dividend. The company's Board of Directors announced the dividend of thirty-four cents ($0.34) per share of common stock will be payable on March 15, 2024, to shareholders of record as of the close of business on March 1, 2024.
Teleflex is recognized for its diverse portfolio of medical technology solutions aimed at enhancing patient health and quality of life. The company's products span a variety of medical fields, including vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology, and respiratory care. Known for its commitment to innovation tailored to meet clinical needs, Teleflex strives to make a meaningful difference in healthcare.
The company's brands, such as Arrow®, Deknatel®, QuikClot®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck®, are well-known in the medical technology industry and share a common mission to improve patient outcomes. Teleflex's global workforce is dedicated to impacting the lives of patients and healthcare providers positively.
This dividend declaration reflects Teleflex's ongoing commitment to providing value to its shareholders and its confidence in the company's financial stability and consistent performance. The dividend payout is part of the company's capital allocation strategy, which aims to balance investment in growth opportunities with returning capital to shareholders.
The information regarding the dividend is based on a press release statement from Teleflex Incorporated. For further details about the company and its offerings, interested parties can visit the official website at teleflex.com.
Teleflex's decision to issue a dividend is a routine aspect of its financial management, and the announcement is a standard communication to its shareholders about such distributions. The company's history of dividend payments is indicative of its financial health and its commitment to returning value to its investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.